-
Iovance's TIL Therapy Generates $12.8 Million in First Quarter Sales
Iovance is building Amtagvi, an immune cell therapy product based on the company's unique autotumor-infiltrating lymphocyte (TIL) technology.
2024-08-09 16:47 -
The Menopause Health Market: Where New Opportunities and Challenges Meet
When discussing the broad landscape of women's health, female menopause is undoubtedly a focus of attention.
2024-08-09 16:46 -
Novartis' Rare Disease Drug Fabhalta Wins FDA Approval for IgAN
A revolutionary drug developed by Novartis Pharmaceuticals, designated for the treatment of immunoglobulin A kidney disease (IgAN). A rare but widespr...
2024-08-08 16:27 -
After 2023 Snub, Amneal Clinches Approval for Extended-Release Parkinson's Disease Med Crexont
Amax Pharmaceuticals finally ushered in a brilliant victory in the United States, its signature innovative delayed release Parkinson's disease treatme...
2024-08-08 16:26 -
Humanwell Healthcare Reports 3.86% Revenue Growth in H1 2024
The latest release shows that Humanwell Healthcare has delivered remarkable results in the first half of 2024, demonstrating excellent market performa...
2024-08-08 16:25 -
The Fast and Furious of the Pharmaceutical Industry: Tragedy and Reflection on Accelerated Approval ...
An amyotrophic lateral sclerosis (ALS) drug with annual sales of $400 million has been mockingly likened by industry analysts to "its efficacy is not ...
2024-08-08 16:25 -
Regulatory Challenges of Gene Therapy and Cancer Drugs: Industry Trends Behind the Withdrawal of Zyd...
In 2022, Gilead announced that it would voluntarily withdraw Zydelig from the U.S. market for two lymphoma treatments, a full six years after it suspe...
2024-08-08 16:24 -
Boehringer Ingelheim's Path to Cancer Research and development: From Acquisitions to the Rise of Inn...
On July 29, Boehringer Ingelheim announced a major acquisition, with plans to buy Nerio Therapeutics for $1.3 billion.
2024-08-07 18:02 -
Biopharma Star Genor Bio Inks Mega Deal to Take its Dual-Targeting Antibody Overseas
Recently, the Hong Kong stock market's innovative pharmaceutical giant - Genor Biological (06998.HK) and the United States biotechnology company TRC20...
2024-08-06 18:14 -
Huarun Acquires 62 Billion Yuan Stake in Chinese Medicine Giant
China's pharmaceutical industry ushered in a major equity change, China Resources Sanjiuannounced that it will buy 28% of Tasly's shares at a high pri...
2024-08-06 18:13
Hot News
- 关于进一步规范化学品信息发布、... Jan 27, 2026
- BASF’s 2025 Report Card—“Th... Jan 27, 2026
- Invista Reshuffles Global Nylo... Jan 28, 2026
- 5%–10% Is Just the Surface: B... Jan 15, 2026
- “Europe’s Chemical Industry ... Feb 02, 2026
Related Products
Related Producers
